|
SH3BGRL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.33750044162673E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.20410406277006E-11 |
| Normal-vs-Stage2 |
1.123800E-01 |
| Normal-vs-Stage3 |
8.384600E-03 |
| Normal-vs-Stage4 |
2.15719999999697E-05 |
| Stage1-vs-Stage2 |
6.591700E-02 |
| Stage1-vs-Stage3 |
5.854000E-02 |
| Stage1-vs-Stage4 |
7.079800E-01 |
| Stage2-vs-Stage3 |
8.382600E-01 |
| Stage2-vs-Stage4 |
2.055800E-01 |
| Stage3-vs-Stage4 |
1.384380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.22969445526655E-11 |
| Normal-vs-AfricanAmerican |
1.998340E-03 |
| Normal-vs-Asian |
3.881700E-02 |
| Caucasian-vs-AfricanAmerican |
2.454300E-02 |
| Caucasian-vs-Asian |
3.977000E-01 |
| AfricanAmerican-vs-Asian |
9.933600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.95210522693878E-11 |
| Normal-vs-Female |
6.213300E-04 |
| Male-vs-Female |
8.539300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.94269999999453E-05 |
| Normal-vs-Extreme_Weight |
1.09919999990993E-07 |
| Normal-vs-Obese |
2.0064999999958E-05 |
| Normal-vs-Extreme_Obese |
2.841300E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.358800E-01 |
| Normal_Weight-vs-Obese |
6.091000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.733200E-01 |
| Extreme_Weight-vs-Obese |
4.089200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.243400E-01 |
| Obese-vs-Extreme_Obese |
1.922160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.58790000000164E-05 |
| Normal-vs-Age(41-60Yrs) |
1.25529999950302E-07 |
| Normal-vs-Age(61-80Yrs) |
5.51489964806251E-10 |
| Normal-vs-Age(81-100Yrs) |
1.116120E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.137800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.927000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.729600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.412640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.186200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.799600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.6214364840248E-12 |
| Normal-VS-Type2 PRCC |
3.183200E-04 |
| Normal-VS-KIRP CIMP |
8.60949999959004E-07 |
| Normal-VS-Unclassified PRCC |
3.841900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.425940E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.068100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.783500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.599400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.462200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.373200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.03620000047844E-07 |
| Normal-vs-N1 |
1.438900E-04 |
| Normal-vs-N2 |
2.131800E-01 |
| N0-vs-N1 |
4.511600E-01 |
| N0-vs-N2 |
3.194600E-01 |
| N1-vs-N2 |
4.053000E-01 |
|
|
